Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1982;80:246-53.
doi: 10.1007/978-3-642-81685-7_39.

Follow-up of a Randomized Trial for Oat Cell Carcinoma Evaluating the Efficacy of Peripheral Intravenous Nutrition (PIVN) as Adjunct Treatment

Clinical Trial

Follow-up of a Randomized Trial for Oat Cell Carcinoma Evaluating the Efficacy of Peripheral Intravenous Nutrition (PIVN) as Adjunct Treatment

B Serrou et al. Recent Results Cancer Res. .


A randomized trial was initiated to compare the effects of peripheral i.v. nutrition (PIVN)-associated chemotherapy (adriamycin, vincristine, VP-16-213, and cyclophosphamide) versus a chemotherapy control group in patients with oat cell lung carcinoma. Thirty-nine evaluable patients were randomized. The test group included 19 patients, whereas 20 were followed in the control group. PIVN was scheduled each day the patient underwent chemotherapy. Each patient received 1,550 kcal day which included 10% glucose, 20% lipids, and amino acids which may or may not have been mixed in the same infusion bottle. The results show ten PIVN patients presently in complete remission at the end of three courses of treatment, compared to nine over the same time period in the chemotherapy control group. Thirty-three percent of patients are still alive after 15 months after the beginning of treatment. There was no significant difference in either general health or side effects, frequency or duration of complete remission, or survival time. After 1 year of treatment, 8 of 19 PIVN patients are still in complete remission, compared to 7 of 20 patients in the control groups.

Similar articles

See all similar articles

Cited by 5 articles

  • Nutrition support in hospitalised adults at nutritional risk.
    Feinberg J, Nielsen EE, Korang SK, Halberg Engell K, Nielsen MS, Zhang K, Didriksen M, Lund L, Lindahl N, Hallum S, Liang N, Xiong W, Yang X, Brunsgaard P, Garioud A, Safi S, Lindschou J, Kondrup J, Gluud C, Jakobsen JC. Feinberg J, et al. Cochrane Database Syst Rev. 2017 May 19;5(5):CD011598. doi: 10.1002/14651858.CD011598.pub2. Cochrane Database Syst Rev. 2017. PMID: 28524930 Free PMC article. Review.
  • Nutrition in Patients with Gastric Cancer: An Update.
    Rosania R, Chiapponi C, Malfertheiner P, Venerito M. Rosania R, et al. Gastrointest Tumors. 2016 May;2(4):178-87. doi: 10.1159/000445188. Epub 2016 Apr 13. Gastrointest Tumors. 2016. PMID: 27403412 Free PMC article. Review.
  • What supports nutritional support?
    Koretz RL. Koretz RL. Dig Dis Sci. 1984 Jun;29(6):577-88. doi: 10.1007/BF01296278. Dig Dis Sci. 1984. PMID: 6426908 Review. No abstract available.
  • Nutritional support: how much for how much?
    Koretz RL. Koretz RL. Gut. 1986 Nov;27 Suppl 1(Suppl 1):85-95. doi: 10.1136/gut.27.suppl_1.85. Gut. 1986. PMID: 3098648 Free PMC article. Review.
  • Protein calorie malnutrition and cancer therapy.
    Parnes HL, Aisner J. Parnes HL, et al. Drug Saf. 1992 Nov-Dec;7(6):404-16. doi: 10.2165/00002018-199207060-00003. Drug Saf. 1992. PMID: 1418697 Review.

Publication types

LinkOut - more resources